This site is intended for healthcare professionals
News

Soleno Therapeutics announces top-line results from phase III trial of DCCR for treatment of Prader-Willi syndrome.

Read time: 4 mins
Last updated:15th Jun 2020
Published:14th Jun 2020
Condition: Prader-Willi Syndrome
Type: drug
Register free for full access to medthority.com